Is this your company? Claim this profile
Genuone Sciences Inc. is a South Korean pharmaceutical CDMO valued at approximately $752 million, offering specialized contract development and manufacturing services including formulation development through finished product production. The company provides pharmaceutical manufacturing and analytical services for both domestic and international clients. Genuone is 100% owned by IMM Private Equity.
Pharmaceutical CDMO, formulation development, finished product manufacturing, analytical services
1 site worldwide